Verenium Corporation (VRNM)
Jefferies 2012 Global Industrial and Aerospace and Defense Conference Transcript
August 7, 2012 10:30 AM ET
Jamie Levine - Chief Executive Officer
Hi, everybody. We could get going to the next presentation here. I’d like to introduce the present CEO of Verenium Corporation, Jamie Levine, and we’re gong have a breakout session in the [Gilliard] room following this presentation.
Thanks everyone in the room and listen by the webcast. I’m Jamie Levine, CEO of Verenium Corporation. I’ll be making some forward-looking statements today and we just advise you to look at our statement here and in our SEC fillings for the associated risks of making those statements.
So I’d like to start with just a brief overview in term of what we are as a company and then a bit about our industry, our products and our future. If look at Verenium today at a glance. We have a sole focus on industrial enzymes market and I’ll talk about what that is in a moment.
But for us, it’s very much about brining a unique and patented enzyme discovery and evaluation platform, which allows us to create highest preforming products, which is a proven model.
We sold $55 million of our products in the last 12 months and in the short-term the focus is on selling more of those products and in the medium-term, it’s about commercializing products out of our pipeline.